Getinge AB Class B 0GZV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 0GZV is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- SEK 191.05
- Day Range
- SEK 186.50–192.45
- 52-Week Range
- SEK 174.50–268.80
- Bid/Ask
- SEK 0.00 / SEK 0.00
- Market Cap
- SEK 52.00 Bil
- Volume/Avg
- 54,579 / 390,407
Key Statistics
- Price/Earnings (Normalized)
- 24.72
- Price/Sales
- 1.84
- Dividend Yield (Trailing)
- 2.03%
- Dividend Yield (Forward)
- 2.03%
- Total Yield
- 2.03%
Company Profile
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 11,862
- Website
- https://www.getinge.com
Competitors
Valuation
|
Metric
|
0GZV
|
MDT
|
TFX
|
|---|---|---|---|
Price/Earnings (Normalized) | 24.72 | 15.58 | 16.00 |
Price/Book Value | 1.83 | 2.16 | 2.29 |
Price/Sales | 1.84 | 3.48 | 3.45 |
Price/Cash Flow | 12.96 | 15.35 | 15.92 |
Price/Earnings
0GZV
MDT
TFX
Financial Strength
|
Metric
|
0GZV
|
MDT
|
TFX
|
|---|---|---|---|
Quick Ratio | 0.75 | 1.46 | 1.20 |
Current Ratio | 1.26 | 2.30 | 2.51 |
Interest Coverage | 7.87 | 8.86 | 4.32 |
Quick Ratio
0GZV
MDT
TFX
Profitability
|
Metric
|
0GZV
|
MDT
|
TFX
|
|---|---|---|---|
Return on Assets (Normalized) | 4.50% | 7.75% | 5.24% |
Return on Equity (Normalized) | 7.71% | 13.75% | 8.81% |
Return on Invested Capital (Normalized) | 6.95% | 9.87% | 7.31% |
Return on Assets
0GZV
MDT
TFX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Bbwsqbxk | Ttffgt | $182.4 Bil | |
SYK
| Stryker Corp | Dqxnvndvcm | Ppzc | $126.5 Bil | |
MDT
| Medtronic PLC | Sqsqlmqj | Cjhsv | $111.9 Bil | |
BSX
| Boston Scientific Corp | Ddxbswbmq | Wlrfysy | $108.0 Bil | |
EW
| Edwards Lifesciences Corp | Vnlcxkzpbb | Wkwgz | $54.3 Bil | |
DXCM
| DexCom Inc | Bzddhmrrhk | Lklk | $52.2 Bil | |
PHG
| Koninklijke Philips NV ADR | Khpscvg | Lzbzq | $25.6 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Gvcsrjmrs | Lxpl | $24.9 Bil | |
ALGN
| Align Technology Inc | Tkdhgzdp | Ngtcd | $20.6 Bil | |
PODD
| Insulet Corp | Btcgbfytv | Hwdddm | $11.3 Bil |